ERBB2 and breast neoplasm: We applied our method to the analysis of human epidermal growth factor receptor 2 (HER2)-positive breast tumor cell (BT474) spheroids treated with the fibroblast growth factor receptor (FGFR) inhibitor AZD4547 37.